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ABSTRACT	  
Background: Criminalization of drug use in Malaysia has led to a concentrated epidemic of HIV 
and substance use disorders within prisons. In response, Malaysia introduced prison-based 
methadone maintenance therapy (MMT) programs to treat opioid dependence and reduce risky 
behaviors. Despite the introduction of this program, MMT uptake has been suboptimal in prison 
settings. Therefore identifying individual-level factors associated with MMT initiation is key to 
improving uptake. 
Methods: 200 incarcerated individuals with a history of opioid use in the 12 months prior to 
incarceration were enrolled in a study to determine factors associated with interest in receiving 
MMT. All participants were 18 years of age or older, had been detained for at least 30 days, and 
were able to speak English or Bahasa Malaysia. Additionally, HIV-positive inmates were 
selectively recruited up to 50%. Logistic regression analysis was used to identify the factors 
associated with MMT interest.  
Findings: Only 85 (43%) participants expressed an interested in receiving MMT, 18 (21%) of 
whom were currently enrolled in the MMT program. Age, ethnicity, religion, education, and 
income were unrelated to interest in MMT (p >0.05).  Conversely, those that were previously 
married (OR=4.15), had a history of incarceration (OR=5.68), depression (OR=3.66), reported 
daily pre-incarceration heroin use (OR=5.53), and had the most favorable attitudes towards 
MMT (OR=19.82) had a greater odds of being interested in receiving MMT (p<0.05).   
Conclusions: Results show that interest in MMT initiation is largely driven by social, legal and 
psychological problems related to drug use. Incarceration provides a unique window of 
opportunity to initiate MMT, and successful uptake of MMT will not be possible without first 
addressing the barriers towards receiving MMT in prison, and how attitudes towards methadone 
impairs MMT interest. 
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INTRODUCTION 
Malaysia is currently facing an epidemic of drug use, with over 300,000 drug users in the 
country, 170,000 of whom are people who inject drugs (PWID) (Vicknasingam and Mazlan, 
2008; WHO, 2011). In 2013 alone, Malaysia accounted for an additional 20,887 drug users, 
75.1% of whom reported opioid use	  (ADK, 2013). Following a period of consistent decline, the 
number of new opioid users in Malaysia has nearly doubled from 8,472 in 2012 to 16,035 in 
2013, while the use of other drugs have either remained the same, or continued to decline	  (ADK, 
2013). Additionally, Malaysia reports the highest prevalence of opioid use at 0.94%, when 
compared to the rest of Southeast Asia (UNODC, 2014). Similarly, Malaysia also reports the 
highest cumulative incidence of HIV due to drug use (76.3%) in all of Southeast Asia, with an 
average of six new infections reported to the Ministry of Health everyday (Chawarski et al., 
2006; MoH, 2011; Suleiman, 2012).    
In response, the Malaysian government introduced several harm reduction programs in 2006, 
including methadone maintenance therapy (MMT) (MoH, 2013). The long history of punitive 
and abstinence only drug policies, however, continue to exist and suspected drug users are 
routinely sent to compulsory drug detention and rehabilitation centers (Pusat Serenti), or prison, 
thereby preventing access to evidence-based treatment, and limiting the success of prevention 
efforts (Kamarulzaman, 2009a). Approximately 45% of all prison inmates in Malaysia are 
convicted on drug charges, and the harsh criminalization of drug use has led to a tremendous 
increase in the number of people who are HIV-positive and opioid dependent in prison (MoH, 
2011; UNODC, 2010).   
In 2008, MMT was extended to 12 prisons, and serves approximately 200 patients in total, 
leaving much room for improvement (Kamarulzaman, 2009b). Evidence from the United States, 
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Australia and Malaysia have demonstrated numerous benefits of initiating MMT within prison, 
including increased adherence to antiretroviral therapy (ART) and viral load suppression for 
those that are HIV-positive (Springer and Bruce, 2008) (Farrell et al., 2005; Kamarulzaman, 
2009a; Wolfe et al., 2010). MMT initiated prior to release also has the potential to reduce needle 
sharing within prison, and prevent relapse to drug use and death from overdose after release. 
Additionally, MMT has proven successful in reducing the rates of criminal behavior and 
recidivism, and ensuring continuity of care and retention in treatment post-release (Binswanger 
et al., 2007; Bruce et al., 2007; Dolan et al., 2003; Dolan et al., 2005; Gordon et al., 2012; 
Gordon et al., 2008; Keen et al., 2000; Kinlock et al., 2009; Kinlock et al., 2007; Stallwitz and 
Stover, 2007).  
Outside of the prison, people who use drugs continue to face a number of structural barriers that 
may inhibit treatment seeking. In Malaysia, MMT users must register with the government, 
which impedes their ability to obtain a driver’s license, gain employment, seek child custody, 
and reinforces the ‘drug user’ label for the duration of treatment (Needle and Zhao, 2010). 
Additionally, police frequently wait outside MMT clinics and target patients for stop and frisk 
searches, subjecting registered users to additional stigma, discrimination, and harassment that 
may impede their desire to initiate treatment (Wickersham et al., 2013). In contrast, initiation of 
MMT within prison may overcome some of these initial barriers to beginning treatment in the 
community.  
Therefore, initiating MMT prior to release from prison is critical in treating opioid dependence 
and halting the spread of HIV. Uptake of MMT in Malaysia has been suboptimal, and an 
enormous gap still exists between those who need treatment and those who actually receive 
treatment. Furthermore, little is known about MMT usage within prisons in Malaysia. Thus, the 
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objective of this study was to identify individual-level factors associated with interest in 
receiving MMT, in order to identify the barriers and facilitators of engaging incarcerated persons 
in treatment.   
MATERIALS & METHODS 
Study Design 
This cross-sectional study was conducted between June and August 2014 in the male 
correctional facility of Kajang State Prison in Selangor, Malaysia located 30 km outside of the 
federal territory of Kuala Lumpur. Kajang State Prison was chosen for this study because it has a 
separate Drug Treatment and Rehabilitation division, and is one of Malaysia’s largest prisons.  
Data Collection 
Participants were identified through convenience sampling, in which prison officials assessed 
initial eligibility and interest in each cellblock. Interested participants were brought to a member 
of the study team, who further assessed eligibility, described the nature of the study, any risks 
and benefits, and obtained verbal consent in a private area. Participants met eligibility criteria if 
they were over the age of 18 years, had used some form of opioids, specified as heroin, morphine 
or opium, in the twelve months prior to incarceration, had been detained for at least 30 days in 
their current incarceration period, were able to speak and understand English or Bahasa 
Malaysia, and were able to provide consent. HIV-positive participants were selectively enrolled 
up to 50% of the study population, and were recruited from a separate cellblock reserved for 
HIV-positive inmates. Foreign residents and those on death row were excluded, as they are not 
eligible to enroll in a prison-based MMT program under Malaysian law. All data was collected 
through the use of structured interviews lasting approximately 45 minutes, and were conducted 
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in either English or Bahasa Malaysia by trained research assistants. Additionally, this study was 
approved by ethical review boards at both Yale University and University of Malaya, and was 
conducted in accordance to standards at Kajang State Prison.  
Study Measures 
The outcome variable used in all analyses was interest in receiving MMT treatment. This was 
defined as either currently receiving MMT within the prison, or interest in receiving MMT if 
they were not currently enrolled in treatment. A broad range of correlates related to interest in 
MMT were examined, including sociodemographic characteristics, incarceration history, co-
morbid conditions, drug use history and psychosocial factors.  
Sociodemographic characteristics included age, ethnicity, religion, marital status, and highest 
level of education completed. Monthly income prior to incarceration was dichotomized as           
≤1000MYR or ≥1001MYR, roughly corresponding to Malaysia’s poverty line income (Hatta and 
Ali, 2013). Prior history of incarceration in prison or in a compulsory drug treatment detention 
center (Pusat Serenti) was also dichotomized as having been previously incarcerated, or not 
having been previously incarcerated.  
All incarcerated individuals are tested for HIV upon arrival to the detention facility, and HIV 
status was pre-determined as HIV-positive or HIV-negative by prison officials. The presence of 
depression was determined through the use of the CES-D questionnaire, in which scores greater 
than ten correspond to depression (Andresen et al., 1994).  
Prior MMT usage, and drug use history and behavior were also assessed. Those that used more 
than three drugs in a day, in the 30 days prior to incarceration were defined as polysubstance 
drug users. Frequency of heroin use in the 30 days prior to incarceration was also determined. 
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Frequency of heroin use was defined as none, if participants did not use heroin in the 30 days 
prior to incarceration, or daily if they reported everyday use of heroin. All others were defined as 
intermittent users. Opioid dependence was determined using the RODS screening tool, where 
participants were defined as opioid dependent if they responded to having three or more 
characteristics related opioid dependence (Wickersham et al., 2015).  
Psychosocial predictors of interest in MMT included addiction severity, treatment readiness, 
opioid use stigma and attitudes towards methadone. Addiction severity was assessed using the 
DAST-10, and was further dichotomized as low or high, in which scores greater than five 
characterized high levels of addiction severity (Skinner, 1982). Treatment readiness was 
measured using SOCRATES-8D, which consists of three subscales measuring recognition of 
problems related to drug use, ambivalence of a drug use problem, and taking steps towards 
making positive changes related to drug use behaviors (Miller and Tonigan, 1996). Opioid use 
stigma was assessed by adapting an abridged version of the Berger HIV Stigma Scale, in which 
the term ‘I have HIV’ was replaced with ‘I use heroin or opioid drugs’ (Berger et al., 2001; 
Jeyaseelan et al., 2013). Subscale measures of opioid use stigma included disclosure concerns, 
negative self-image, public attitudes, and personalized stigma related to opioid drug use. Finally, 
questions assessing attitudes towards MMT were adapted from the Attitudes towards Methadone 
scale developed by Schwartz et al. (2008), and have been previously used in Malaysia by Vijay 
et al. (2015). A summary score measuring MMT attitudes was created, in which scores ranging 
from 0 to 5, 6 to 8 and 9 to 11 were characterized as low, moderate or high levels of favorable 
attitudes towards treatment, respectively.  
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Data Analysis 
The analysis for this study proceeded in four steps. First, descriptive statistics were generated 
through frequencies of categorical predictor variables, or the mean and standard deviation for 
continuous variables. Second, bivariate associations between predictor variables and interest in 
MMT were calculated using the Pearson’s chi-square test, or a two-sided Student’s t-test for 
independent samples. A multivariate analysis was then performed using logistic regression, in 
which the reported odds ratios (OR) and 95% confidence intervals are estimates of the likelihood 
of being interested in receiving MMT. A p-value of 0.10 was used as the criterion for selection 
into the multivariate logistic regression model. Backwards elimination was used to obtain the 
final model, in which all predictor variables significant at a p-value of 0.05 were retained. 
Finally, a Pearson’s chi-square test was used to determine which specific attitudes towards 
methadone were significant in predicting interest in MMT. All data analysis was completed 
using IBM SPSS Statistics (SPSS Inc., Chicago, IL, USA) and SAS, version 9.3 (SAS Institute 
Inc, Cary, NC, USA). 
 
RESULTS 
Table 1 describes the baseline characteristics of study participants, and differences between those 
interested and not interested in receiving MMT. With regards to baseline characteristics, the 
mean age was 40.9 years old (range= 21 - 61 years), with the majority of participants being 
ethnically Malay (71.0%), Muslim (77.5%), and having never married (65.0%). Approximately 
one-third of the sample reported earning equal to or less than 1000 MYR/month ($303/month), 
and reported polysubstance use. The majority of participants had previously been incarcerated 
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(86.9%; mean = 5.4 years, range= 1 month – 35 years) or detained in a compulsory drug 
rehabilitation center (59.8%; mean = 2.7 years, range = 2 weeks – 8 years). Approximately half 
the sample had previous experience using MMT as prescribed by a doctor. Although 95% of the 
sample was opioid-dependent, 60% were characterized as having high addiction severity, and 
66.5% reported daily heroin use in the 30 days prior to incarceration.  
Treatment readiness is further divided into three subscales measuring recognition, ambivalence 
and taking steps. Recognition subscale scores ranged from 19 to 35 (mean = 27.1 ± 3.2), 
Ambivalence subscales ranged from 8 to 20 (mean = 14.6 ± 2.0) and the taking steps subscale 
ranged from 16 to 40 (mean = 31.0 ± 4.0). Total stigma scores ranged from 45 to 92 (mean = 
65.2 ± 8.2), disclosure concerns related to heroin and other opioid use ranged from 9 to 20 (mean 
= 14.7 ± 2.0), negative self-image ranged from 8 to 20 (mean = 14.1 ± 2.1), public attitudes 
ranged from 10 to 20 (mean = 22.0 ± 3.6), and personalized stigma ranged from 13 to 32 (mean 
= 22.0 ± 3.6). MMT attitudes scores were divided into quartiles, approximately 25% had low or 
high levels of positive MMT attitudes, and approximately 50% had moderate levels of positive 
MMT attitudes.  
Eighty-five (42.5%) of the participants surveyed expressed an interest in receiving MMT, of 
which 18 (21.2%) were currently receiving MMT within the prison. There were no significant 
differences between those interested in MMT and those uninterested in MMT, by age, ethnicity, 
religion, marital status, educational attainment, monthly income, compulsory drug treatment 
history, HIV status, depression, addiction severity, treatment readiness, or opioid use stigma (p 
>0.05). Differences in MMT interest were observed by incarceration history, previous experience 
with MMT use, pre-incarceration polysubstance drug use, lifetime injection drug use, frequency 
of pre-incarceration heroin use, and attitudes towards MMT (p <0.05).  
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Table 2 represents the results of bivariate and multivariate logistic regression analysis. In the 
bivariate analysis, those that were not currently married, had prior history of incarceration, had 
prior experiences with MMT usage, reported polysubstance use in the 30 days prior to 
incarceration, reported injection drug use ever in their lifetime, reported any use of heroin in the 
30 days prior to incarceration, and had moderate or high levels of positive attitudes towards 
MMT were significantly more likely to be interested in receiving MMT (p <0.05). Additionally, 
those with greater recognition of their drug dependence as a problem, and those that faced 
greater stigma related to public attitudes and personalized stigma were significantly more likely 
to be interested in receiving MMT (p <0.05). Upon adjusting for all bivariate predictors 
significant at the p=0.10 level, marital status, prior history of incarceration, depression, 
frequency of drug use, and MMT attitudes remained significant. Those that were previously 
married were 4.15 (95% CI: 1.15, 15.02) times more likely to be interested in MMT treatment 
than those that are currently married. Those that are depressed are 3.66 (95% CI: 1.68, 7.98) 
times more likely to be interested in treatment. Compared to those that reported no heroin use, 
those that used heroin daily in the 30 days prior to prison were 5.53 (95% CI: 1.65, 18.58) times 
more likely to be interested in MMT. And finally, those with the highest levels of positive 
attitudes toward MMT treatment were 19.82 (95% CI: 6.07, 64.74) times more likely to be 
interested in receiving MMT as treatment.  
Table 3 describes the proportion of participants who agreed or disagreed with each statement 
addressing individual attitudes towards MMT. P-values signify whether each statement was 
independently associated with interest in receiving MMT. The majority of participants agreed 
with affirmative statements regarding MMT treatment for opioid dependence. These included 
statements indicating that being on methadone therapy would keep them from injecting, stay out 
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of prison or Pusat Serenti, improve the quality of their life, and is the best way to treat opioid 
addiction. All these statements were significantly predictive of interest in receiving MMT (p 
<0.05). On the other hand, many disagreed with negative statements regarding MMT treatment. 
The majority of participants did not believe that their religion would not permit them to use 
methadone, that doctors treat addicts poorly, and that people look down on those who use 
methadone. Approximately half of all participants believed that methadone is bad for a person’s 
health, and that methadone only encourages people to use more of other drugs. Finally, 
approximately 75% of all participants believed that methadone only replaces one addiction for 
another, and that people should try to get off methadone therapy as soon as possible. Only 
statements related to religious beliefs, and health beliefs were significantly predictive of interest 
in MMT (p <0.05).   
 
DISCUSSION 
This is the first study to examine factors related to interest in receiving methadone treatment for 
opioid dependence amongst those incarcerated in Malaysia. Identifying factors related to seeking 
MMT may make it easier to identify potential candidates who may have more successful 
treatment outcomes, and greater retention to care. The numerous benefits of implementing MMT 
prior to release indicates that ensuring uptake of treatment has important implications for 
continuity of care, and secondary HIV prevention. This study reveals that less than half of those 
incarcerated with a history of opioid use will want to enroll in methadone treatment in prison, 
despite the fact that 95% met the criteria for opioid dependence. We found that those wishing to 
enroll in treatment are more likely to have prior convictions and report daily heroin use prior to 
incarceration, possibly indicating greater addiction severity. Similar to our findings, Rounsaville 
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and Kleber (1985) found that treatment seeking opiate users were more likely to suffer from 
major depression, and have poorer social outcomes due to drug use, which may be explicative of 
the finding that those that displayed clinically depressive symptoms, and those that were 
previously married are more likely to be interested in MMT.  
This study also found that attitudes toward methadone had the greatest effect on interest in 
receiving methadone as treatment for opioid dependence. Those with the most favorable attitudes 
were almost twenty times as likely to be interested in methadone when compared to those with 
the least favorable attitudes. Even a moderate increase in favorable attitudes towards methadone 
can have a profound effect, making individuals almost eight times more likely to be interested in 
MMT. Although it is generally known that those with better attitudes toward medication-assisted 
treatment will have better treatment outcomes, this study helps identify exactly which factors 
need to be addressed through education and awareness campaigns. (Bachireddy et al., 2011; Rich 
et al., 2005; Vijay et al., 2015). This finding has important implications for future public health 
interventions that aim to increase treatment motivation and uptake of MMT.  
Surprisingly, only 43% of the participants surveyed indicated interest in MMT, despite the fact 
that few participants expressed negative attitudes, and that the majority expressed favorable 
attitudes towards MMT. This discordance between attitudes and interest in treatment uptake may 
indicate that an additional, unmeasured factor mediates the relationship between attitudes and 
treatment seeking. A lack of treatment knowledge may pose an additional barrier for those 
eligible for methadone treatment, and may partially explain the lack of treatment interest in the 
57% that did not wish to receive methadone. Previous studies from Australia and the U.S. have 
examined the attitudes of correctional staff towards medication-assisted treatment, and found that 
staff members are largely unaware of the risks and benefits of MMT, and favor abstinence-
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related treatment over pharmacological interventions, suggesting an opportunity for education 
amongst treatment providers and the drug using population (Bruce et al., 2007; Gjersing et al., 
2007; Rich et al., 2005). This study also revealed that stigma continues to exist in this 
population, and the compounded stigma of HIV and drug use, especially in healthcare settings, 
may impose a significant barrier to seeking treatment (Bruce et al., 2007; Choi et al., 2010; 
Earnshaw et al., 2013; Jin et al., 2014).  
The results from this study identify the factors associated with interest in receiving MMT within 
prison. Marital status, incarceration history, depression, and frequency of heroin use may serve 
as identifiers for those motivated to seek treatment, who may have more successful uptake, and 
have greater retention in care. Among those uninterested in receiving treatment, awareness and 
education regarding MMT as a harm reduction approach is imperative in dispelling the negative 
myths and stigma surrounding methadone usage. The findings from this study demonstrate that 
having favorable beliefs regarding methadone may have the greatest impact on interest in 
receiving MMT. Therefore, changing the attitudes and beliefs about methadone may serve as a 
target for future public health interventions, in order to increase treatment motivation and 
increase treatment uptake.  
 
Limitations 
Although several predictors of interest in enrolling in MMT emerged from this study, the 
findings may be limited by the sampling method used to recruit participants. All participants 
were recruited from a single correctional institution, potentially limiting the generalizability to 
Kajang Prison or Malaysia as a whole. Additionally, the cross-sectional nature of this study does 
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not infer causality, but rather significant associations. Finally, although the structured interview 
was extensive, it is impossible to cover all individual-level factors related to methadone seeking. 
Nonetheless, this study provides important insight into factors associated with interest in 
receiving MMT among prisoners in Malaysia with a history of opioid use, which may be critical 
in identifying those most motivated to seek treatment and those that may have the greatest 
retention to care.  
 
CONCLUSION 
Incarceration provides a unique window of opportunity to initiate MMT, and is a critical harm 
reduction strategy. Overall, interest in MMT initiation is largely driven by social, legal and 
psychological problems related to drug use and incarceration. More specifically, the findings 
from this study demonstrate that marital status, incarceration history, depression, frequency of 
heroin use prior to incarceration and favorable attitudes toward MMT are significantly associated 
with interest in methadone treatment. Further investigation into how treatment motivation affects 
MMT interest is warranted, especially in the context of prisons. Despite continuous efforts to 
introduce MMT into the prison system, successful uptake of MMT will not be possible without 
first addressing treatment attitudes, and systematic barriers preventing the expansion of MMT 
programs within prison. 
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